Background Patients with coronavirus disease 2019 (COVID-19) experience a wide clinical
spectrum, with over 2% developing fatal outcome. The prognostic factors for fatal outcome …

During a severe infection such as coronavirus disease 2019 (COVID-19), the level of almost
all analytes can change, presenting a correlation with disease severity and survival; …

The outbreak of coronavirus disease (COVID-19) has brought great challenges to the world.
The objectives of this study were to describe the baseline characteristics and changes of …

Background Prognostic markers for disease severity and identification of therapeutic targets
in COVID‐19 are urgently needed. We have studied innate and adaptive immunity on …

Background Identifying the immune cells involved in coronavirus disease 2019 (COVID-19)
disease progression and the predictors of poor outcomes is important to manage patients …

Background The outbreak of coronavirus disease 2019 (COVID-19) in Wuhan City, China
has spreads rapidly since December, 2019. Most patients show mild symptoms, but some of …

Background The effectual immune response is crucial to defeat viral infections. However,
exuberant immune response with features of macrophage activation syndrome (MAS) lead …

Coronavirus disease 2019 (COVID-19) has resulted in a global pandemic, challenging both
the medical and scientific community for the development of novel vaccines and a greater …

Purpose Cytokine storm, an uncontrolled overproduction of inflammatory cytokines
contributing to an aberrant systemic inflammatory response, is a major pathological feature …

Purpose Cytokines are major mediators of COVID-19 pathogenesis and several of them are
already being regarded as predictive markers for the clinical course and outcome of COVID …